Spending through the 340B Drug Pricing Program rose by 565% between 2010 and 2021, increasing from $6.6 billion to $43.9 billion, according to a report from the Congressional Budget Office. In 2021, ...

A bipartisan group of 163 lawmakers is urging the Department of Health and Human Services (HHS) to cancel an upcoming pilot ...

Congress is considering a new bill that, in theory, would boost low-income patients’ - especially Latinos’ - access to ...

Hospitals are up in arms over new guidance issued by the Health Resources and Services Administration on Thursday that could restrict the eligibility of their outpatient clinics for drug discounts in ...

The 340B Drug Pricing Program (340B program) is a federal drug discount program that requires drug manufacturers participating in the Medicaid drug rebate program to provide outpatient drugs to ...

The 100% woman-owned consulting firm partners with healthcare organizations to help them understand, implement, and optimize ...

The hospital lobby wants the Trump administration to investigate Johnson & Johnson, Eli Lilly, Sanofi, Novartis and Bristol ...

The results indicate that the program could play a role in discouraging use of biosimilars in the United States. Hospitals participating in the 340B Drug Pricing Program had lower biosimilar uptake, ...

Hospitals and small organizations should have equal levels of oversight and scrutiny. One of the critical components for Mainers as they navigate the medical quagmire of insurance, providers and ...